12° SEMINARIO QUÍMICA ORGÁNICA IQUIR 2020

SEMINARIO QUÍMICA ORGÁNICA 03-08-20
TÍTULO: "Total Synthesis and Biological Evaluation of Tiancimycins A and B, Yangpumicin A, and Related Anthraquinone-Fused Enediyne Antitumor Antibiotics"
FUENTE: K. C. Nicolaou et al. J. Am. Chem. Soc. 2020, 142, 2549−2561.
EXPOSITOR: Qco. Santiago Bolivar
DÍA, HORA y LUGAR: Lunes 03 de agosto de 2020, 17:30 h, Plataforma MEET GOOGLE.
Link: meet.google.com/ksi-cypi-pif

LinkPresentación: https://drive.google.com/file/d/1rniNOwHzP56xBLBp1Fg4cBJriLx9NJF3/view?ts=5f288ddf

RESUMEN:

The family of anthraquinone-fused enediyne antitumor antibiotics was established by the discovery of dynemicin A and deoxy- dynemicin A. It was then expanded, first by the isolation of uncialamycin, and then by the addition to the family of tiancimycins A−F and yangpumicin A. This family of natural products provides opportunities in total synthesis, biology, and medicine due to their novel and challenging molecular structures, intriguing biological properties and mechanism of action, and potential in targeted cancer therapies. Herein, the total syntheses of tiancimycins A and B, yangpumicin A, and a number of related anthraquinone-fused enediynes are described. Biological evaluation of the synthesized compounds revealed extremely potent cytotoxicities against a number of cell lines, thus enriching the structure−activity relationships within this class of compounds. The findings of these studies may facilitate future investigations directed toward antibody−drug conjugates for targeted cancer therapies and provide inspiration for further advances in total synthesis and chemical biology